DK1900362T3 - Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser - Google Patents

Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser

Info

Publication number
DK1900362T3
DK1900362T3 DK07022078.5T DK07022078T DK1900362T3 DK 1900362 T3 DK1900362 T3 DK 1900362T3 DK 07022078 T DK07022078 T DK 07022078T DK 1900362 T3 DK1900362 T3 DK 1900362T3
Authority
DK
Denmark
Prior art keywords
treatment
alpha
addictive disorders
derivatives useful
aminoamide derivatives
Prior art date
Application number
DK07022078.5T
Other languages
English (en)
Inventor
Elena Barbanti
Emanuela Izzo
Ruggero Fariello
Patricia Salvati
Luca Benatti
Claudia Besana
Florian Thaler
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Application granted granted Critical
Publication of DK1900362T3 publication Critical patent/DK1900362T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK07022078.5T 2004-04-22 2005-04-19 Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser DK1900362T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04009532A EP1588704A1 (en) 2004-04-22 2004-04-22 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
EP05736365A EP1737438B1 (en) 2004-04-22 2005-04-19 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome

Publications (1)

Publication Number Publication Date
DK1900362T3 true DK1900362T3 (da) 2011-05-09

Family

ID=34924693

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05736365T DK1737438T3 (da) 2004-04-22 2005-04-19 Alfa-aminoamidderivater til behandling af syndromet restless legs
DK07022078.5T DK1900362T3 (da) 2004-04-22 2005-04-19 Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05736365T DK1737438T3 (da) 2004-04-22 2005-04-19 Alfa-aminoamidderivater til behandling af syndromet restless legs

Country Status (26)

Country Link
US (2) US8445513B2 (da)
EP (3) EP1588704A1 (da)
JP (1) JP5020069B2 (da)
KR (2) KR101238377B1 (da)
CN (1) CN1942179B (da)
AT (2) ATE494890T1 (da)
AU (1) AU2005235428B2 (da)
BR (2) BRPI0509976B8 (da)
CA (1) CA2563674C (da)
CY (2) CY1108494T1 (da)
DE (2) DE602005009162D1 (da)
DK (2) DK1737438T3 (da)
ES (2) ES2313330T3 (da)
HK (1) HK1099216A1 (da)
HR (2) HRP20080593T3 (da)
IL (1) IL178732A (da)
ME (2) ME02324B (da)
MX (1) MXPA06012163A (da)
NO (2) NO337900B1 (da)
NZ (1) NZ550664A (da)
PL (2) PL1737438T3 (da)
PT (2) PT1737438E (da)
RS (2) RS50667B (da)
RU (1) RU2403030C2 (da)
SI (2) SI1900362T1 (da)
WO (1) WO2005102300A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
JP4350508B2 (ja) * 2001-09-03 2009-10-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
CA2536764C (en) * 2003-08-25 2013-09-17 Newron Pharmaceuticals, S.P.A. .alpha.-aminoamide derivatives useful as anti-inflammatory agents
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
BRPI0515154A (pt) * 2004-09-10 2008-07-08 Newron Pharm Spa uso de (halobenzilóxi)benzilamino-propanamidas para a fabricação de medicamentos ativos, compostos e composição farmacêutica
EP1812070B1 (en) * 2004-11-10 2013-10-02 Orion Corporation Treatment of restless legs syndrome
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
NZ571591A (en) * 2006-04-03 2011-09-30 Teva Pharma Use of rasagiline for the treatment of restless legs syndrome
EP1870097A1 (en) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
PT2029524E (pt) * 2006-06-19 2015-03-09 Newron Pharm Spa Processo para a produção de 2-[4-(3- e 2-fluorobenziloxi benzilamino]propanamidas
GB0706630D0 (en) * 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
AU2008261325B2 (en) 2007-06-15 2012-12-06 Newron Pharmaceuticals S.P.A. Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
CN104523668B (zh) * 2007-12-11 2020-06-09 纽朗制药有限公司 高纯度的2-[4-(3-或2-氟苄氧基)苄氨基]丙酰胺类及其用途
JP5736175B2 (ja) * 2007-12-19 2015-06-17 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー 精神障害の治療に有用なα−アミノアミド誘導体
EP2314569A1 (en) 2009-10-22 2011-04-27 Merck Patent GmbH Novel polymorphic forms of (S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof
WO2011134763A1 (en) 2010-04-27 2011-11-03 Newron Pharmaceuticals S.P.A. Process for the production of ralfinamide methanesulfonate salts or their r-enantiomers
US11278651B2 (en) * 2018-10-17 2022-03-22 Gambro Lundia Ab Membrane and device for treating restless leg syndrome
CN114667963B (zh) * 2020-12-24 2024-04-26 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物药物成瘾性评估的装置

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4935429A (en) * 1985-10-25 1990-06-19 Dackis Charles A Method of treating psychostimulant addiction
JP2736103B2 (ja) * 1988-03-01 1998-04-02 ヴァルター・ビルクマイヤー パーキンソン症候群の治療用医薬、およびその製造方法
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5221536A (en) * 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
EP0520325A1 (de) * 1991-06-28 1992-12-30 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Monoaminoxidase-B-Hemmern zur Verhütung und Behandlung von Entzugserscheinungen nach Alkohol- und Drogenmissbrauch
GB9306886D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
IL111240A (en) * 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
JPH11505828A (ja) * 1995-05-26 1999-05-25 ファイザー・インコーポレーテッド パーキンソン症候群の治療用の選択的ｎｍｄａアンタゴニスト含有組合せ
AU3155995A (en) 1995-06-17 1997-01-15 Gunter Baumann Disc-shaped member
GB9515411D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa N-(4-substituted-benzyl)-2-aminolactam derivatives
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9727521D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Substituted 2-benzylamino-2-phenyl-acetamide compounds
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
CA2317399C (en) 1998-01-12 2009-01-27 Deborah Wenzel An additive composition also used as a fuel composition comprising water soluble alcohols
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
WO2001034172A2 (en) * 1999-11-05 2001-05-17 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
WO2001041763A1 (en) * 1999-12-10 2001-06-14 University Of Cincinnati Treatment of addiction disorders
US20020019421A1 (en) * 2000-07-05 2002-02-14 Roni Biberman Compositions and therapy for substance addiction
EP1406631A4 (en) * 2001-06-13 2005-03-23 Univ Michigan DOPAMINE RECEPTOR LIGANDS AND CORRESPONDING THERAPEUTIC METHODS
MXPA04011594A (es) * 2002-05-29 2005-03-07 Hoffmann La Roche Derivados n-acilaminobenceno como inhibidores selectivos de monoamino oxidasa b.
WO2004000742A2 (en) 2002-06-24 2003-12-31 Rockwool International A/S Process and apparatus for controlling mineral wool production using a cascade rotor
US6900354B2 (en) * 2002-07-15 2005-05-31 Hoffman-La Roche Inc. 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
JP2005060370A (ja) * 2003-07-25 2005-03-10 Kyowa Hakko Kogyo Co Ltd 医薬組成物
EP1524267A1 (en) * 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Substituted benzylaminoalkylene heterocycles
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders

Also Published As

Publication number Publication date
KR101195819B1 (ko) 2012-11-05
ME01219B (me) 2013-06-20
SI1737438T1 (sl) 2008-12-31
RS50667B (sr) 2010-06-30
US8445513B2 (en) 2013-05-21
ES2313330T3 (es) 2009-03-01
NO20150971L (no) 2006-11-22
NO338870B1 (no) 2016-10-31
KR20120028399A (ko) 2012-03-22
RU2006137079A (ru) 2008-04-27
CA2563674A1 (en) 2005-11-03
JP5020069B2 (ja) 2012-09-05
US8697738B2 (en) 2014-04-15
ATE494890T1 (de) 2011-01-15
HK1099216A1 (en) 2007-08-10
US20130217747A1 (en) 2013-08-22
AU2005235428A1 (en) 2005-11-03
NO337900B1 (no) 2016-07-04
US20070203182A1 (en) 2007-08-30
JP2007533691A (ja) 2007-11-22
DK1737438T3 (da) 2008-12-08
BRPI0509976B8 (pt) 2021-05-25
AU2005235428B2 (en) 2010-03-18
DE602005009162D1 (de) 2008-10-02
RU2403030C2 (ru) 2010-11-10
BRPI0509976A (pt) 2007-10-16
IL178732A0 (en) 2007-05-15
EP1588704A1 (en) 2005-10-26
CA2563674C (en) 2012-12-18
IL178732A (en) 2013-01-31
DE602005025941D1 (de) 2011-02-24
EP1900362B1 (en) 2011-01-12
KR101238377B1 (ko) 2013-03-04
NZ550664A (en) 2010-08-27
RS51791B (en) 2011-12-31
MXPA06012163A (es) 2007-01-17
PT1737438E (pt) 2008-12-22
HRP20110230T1 (hr) 2011-04-30
BR122020004541B1 (pt) 2021-11-09
KR20070042914A (ko) 2007-04-24
BRPI0509976B1 (pt) 2020-10-06
EP1737438A1 (en) 2007-01-03
SI1900362T1 (sl) 2011-03-31
CY1108494T1 (el) 2014-04-09
EP1900362A3 (en) 2009-04-01
WO2005102300A1 (en) 2005-11-03
ES2357559T3 (es) 2011-04-27
CN1942179A (zh) 2007-04-04
ME02324B (me) 2016-06-20
EP1900362A2 (en) 2008-03-19
PL1900362T3 (pl) 2011-06-30
PT1900362E (pt) 2011-03-09
NO20064732L (no) 2006-11-22
PL1737438T3 (pl) 2009-01-30
CY1111656T1 (el) 2015-10-07
CN1942179B (zh) 2010-08-11
EP1737438B1 (en) 2008-08-20
ATE405256T1 (de) 2008-09-15
HRP20080593T3 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
DK1900362T3 (da) Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser
LTC1971601I2 (da)
HUS1900005I1 (hu) Javított nanotestek (TM) aggregáció közvetítette rendellenességek kezelésére
DK1730119T3 (da) Imidazolforbindelser til behandling af neurodegenerative forstyrrelser
DK3567035T3 (da) N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer
IL191283A (en) Compositions for treating eye irregularities
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
BRPI0509660A (pt) compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias
NL1030418A1 (nl) Azabenzoxazolen voor de behandeling van CZS-stoornissen.
EP1814535A4 (en) NITROSED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING EYE DISEASES
WO2010030891A3 (en) Aryl guanidine f1f0-atpase inhibitors and related methods
IL177955A0 (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
DK1907374T3 (da) Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
PT2366393E (pt) Roflumilaste para o tratamento da hipertensão pulmonar
DK1940447T3 (da) Behandling af neurodegenrative lidelser
IL185653A (en) Antibodies that call for the 1-kim salt region
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen
DK1909800T3 (da) Acylglycerophospholipider til behandling af symptomer i forbindelse med cancer
FR2871246B1 (fr) Lunettes
WO2006060202A3 (en) Imidazole derivatives for the treatment of psychiatric disorders